News: Cannabinoid research programme

Cannabinoid biomedicine research programme launched: Oxford University and Kingsley Capital Partners have launched a new research programme to investigate the role of cannabinoids in biology and medicine. The programme aims to develop new therapies for acute and chronic conditions including pain, cancer and inflammatory disease. Through an initial investment of up to £10 million provided... Continue Reading →

Powered by WordPress.com.

Up ↑